McGrath Yvonne

CIK 00018162131 companyWATERTOWN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001816213

Recent Transactions

34 trades

Disposition from Tender
iTeos Therapeutics, Inc.
Common Stock
2025-08-29−46,300→ 0 total
Disposition to Issuer
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2025-08-29−16,054→ 0 total
Disposition to Issuer
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2025-08-29−69,069→ 0 total
Disposition to Issuer
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2025-08-29−91,000→ 0 total
Award
iTeos Therapeutics, Inc.
Common Stock
2025-03-07+15,300→ 46,300 total
Award
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2025-03-07+91,000→ 91,000 total
Award
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2024-03-07+153,600→ 153,600 total
Award
iTeos Therapeutics, Inc.
Common Stock
2023-12-05+31,000→ 31,000 total
Award
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2023-03-09+130,000→ 130,000 total
Award
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2022-03-11+85,000→ 85,000 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2022-03-01$36.76/sh−10,000→ 0 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Common Stock
2022-03-01$4.24/sh+10,000→ 10,000 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2022-03-01−10,000→ 85,123 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Common Stock
2021-06-08$4.23/sh+7,927→ 7,927 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-06-08−7,927→ 95,123 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-06-08$20.00/sh−7,927→ 0 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-06-02$20.00/sh−323→ 0 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-06-02−323→ 103,050 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Common Stock
2021-06-02$4.23/sh+323→ 323 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Common Stock
2021-06-01$4.23/sh+7,604→ 7,604 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-06-01−7,604→ 103,373 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-06-01$20.18/sh−7,604→ 0 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-05-24−7,927→ 110,977 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Common Stock
2021-05-24$4.23/sh+7,927→ 7,927 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Common Stock
2021-05-24$4.23/sh+7,927→ 7,927 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-05-24−7,927→ 110,977 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-05-24$21.92/sh−7,927→ 0 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-05-24$21.92/sh−7,927→ 0 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-05-17$24.41/sh−5,807→ 2,119 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Common Stock
2021-05-17$4.23/sh+7,926→ 7,926 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-05-17$25.43/sh−2,029→ 90 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-05-17$26.01/sh−90→ 0 total
Exercise/Conversion
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-05-17−7,926→ 118,904 total
Award
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-01+45,000→ 45,000 total

Companies

iTeos Therapeutics, Inc.
Chief Scientific Officer

Recent Filings

Address

C/O ITEOS THERAPEUTICS, INC. 321 ARSENAL STREET

WATERTOWN, MA, 02472

View on SEC.gov